BTG3 and rheumatoid arthritis: Earlier studies also revealed the expressive correlation between aggressive RA and high anti-CCP titer, and also ANA positivity.[27–29] Furthermore, statistically significant difference between DAS28-CRP after 4 months of treatment initiation and ΔDAS28-CRP among RA patients with and without thyroid disorders supported this point of view.